Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
Rev. Soc. Bras. Med. Trop ; 51(4): 554-556, July-Aug. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-957447

RESUMEN

Abstract Staphylococcus lugdunensis is a rare virulent coagulase-negative staphylococcus (CoNS) that behaves similarly to Staphylococcus aureus in causing deep abscesses, skin and soft tissue infections, and central nervous system infections. Additionally, there can be certain blood stream infections including sepsis, septic shock, toxic shock syndrome, and endocarditis complicated by embolic events. Reports of septic arthritis of a native joint associated with this organism have been infrequent, justifying the presentation and discussion of this case.


Asunto(s)
Humanos , Masculino , Infecciones Estafilocócicas/microbiología , Artritis Infecciosa/microbiología , Staphylococcus lugdunensis/aislamiento & purificación , Articulación de la Cadera/microbiología , Infecciones Estafilocócicas/diagnóstico , Infecciones Estafilocócicas/tratamiento farmacológico , Artritis Infecciosa/diagnóstico , Artritis Infecciosa/tratamiento farmacológico , Tomografía Computarizada por Rayos X , Persona de Mediana Edad , Antibacterianos/uso terapéutico , Nafcilina/uso terapéutico
2.
Rev. Soc. Bras. Med. Trop ; 49(2): 258-259, Mar.-Apr. 2016. tab
Artículo en Inglés | LILACS | ID: lil-782104

RESUMEN

Abstract: Vancomycin is the first-line agent for the treatment of bacteremia, endocarditis, pneumonia, cellulitis, and osteomyelitis. Pancytopenia is an uncommon adverse effect of vancomycin therapy, with only a few cases of vancomycin-related neutropenia and pancytopenia described in the literature. We describe a case of a 56-year-old man who was diagnosed with chronic paraspinal abscess and started on intravenous vancomycin. He was re-admitted two weeks later with new-onset pancytopenia. Discontinuation of vancomycin resulted in improved cell counts. Physicians should monitor cell counts in patients who are on long-term intravenous vancomycin.


Asunto(s)
Humanos , Masculino , Vancomicina/efectos adversos , Antibacterianos/efectos adversos , Pancitopenia/inducido químicamente , Enfermedades de la Columna Vertebral/tratamiento farmacológico , Vancomicina/uso terapéutico , Absceso/tratamiento farmacológico , Persona de Mediana Edad , Antibacterianos/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA